Skip to content

SCHEDULE 13D/AAccepted Oct 30, 4:08 PM ET

Abivax S.A. SCHEDULE 13D/A

Sofinnova Crossover I

Accepted (ET)

4:08 PM

Oct 30, 2025

Filed

Oct 30, 2025

Documents

1

Size

26.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.